SCHWARZENBRUCK, 26 April 2016 – IBA (Ion Beam Applications S.A.), the global high-tech leader in the next generation of proton therapy solutions and radiation therapy dosimetry for the treatment of cancer, announces the release of the next evolution in patient safety, Dolphin Online Ready Patient QA and Monitoring. Designed to revolutionize patient QA, leading to more efficiency and better patient safety, Dolphin enhances workflows in pre- treatment QA, while being mindful of future online treatment monitoring.

To achieve added efficiency, Dolphin offers a “plug and play” design that enables significantly faster pre-treatment QA. Dolphin only requires two minutes to set up and wirelessly transmits the measured detector response to the Dolphin workstation. Additionally, the new automatic verification software QuickCheck™ saves valuable time by providing instant analysis of the Dolphin measurements and giving an “OK” message for the tests successfully passed.

This design ensures that Dolphin will enable future online treatment monitoring by measuring the actual delivery during patient treatment and by automatic QuickCheck verification immediately after each fraction seamlessly integrating into the therapist’s workflow.
“The Dolphin will offer the possibility for online verification of complex dose delivery techniques such as IMRT or VMAT with the patient already in treatment position. Used for multiple treatment fractions the system even offers inherently a new possibility for cumulative delivered dose tracking,” said Dr. Hansjoerg Wertz, Dept. of Radiation Oncology, University Medical Centre Mannheim, University of Heidelberg, Mannheim, Germany in the name of the whole “dolphin team” at UMM. “The novel online QA system contributes to reduce extra pre-treatment QA time to a minimum while at the same time increasing patient safety and preventing severe accidents due to the immediate detection of dose delivery errors. Based on our intensive initial experiences we are planning to implement Dolphin into our clinical routine workflow for our patient verification during treatment as soon as possible. This gives us the ultimate confidence in treating our patients safely.”

Dolphin offers not only a simple consistency check but is coupled with the advanced analysis of each measured dose, and in turn, offers a complete patient QA solution. The clinical relevance of the dose discrepancies is comprehensively determined with DVH and in 3D patient anatomy using sophisticated TPS-Class verification software. Following this verification process, the clinical team can determine whether re-planning or plan adaptation is needed or machine-specific parameters can be verified.

Products and Clearances Homepage